Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe; an Observational Pharmacokinetic Study

NCT04935255 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04935255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04935255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe; an Observational Pharmacokinetic Study
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
August 11, 2021
Completion date
June 23, 2022
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

testicular cancer